The National Institute on Drug Abuse (NIDA) Intramural Research Program will hold a one-day symposium to summarize the most recent advances in opioid research. Topics range from the use of a therapeutic workplace to address opioid use disorders to basic research such as findings regarding the role of D3 antagonists in opioid reward.
WHEN: May 22, 2019; 8:50 AM – 5:00 PM EST
WHERE: Biomedical Research Center, Johns Hopkins Bayview Campus, 251 Bayview Blvd. Baltimore, MD 21224
*All attendees must have current, official Government identification to enter the building. NO EXCEPTIONS.
WHO: Amy Hauck Newman, Ph.D., acting scientific director of NIDA’s Intramural Research Program, is available to comment on the research.
Symposium will include lectures from intramural and extramural researchers from industry, academia and the government. See list of speakers (subject to change): https://www.drugabuse.gov/news-events/meetings-events/2019/05/nida-irp-opioid-translational-research-symposium
CONTACT: If you are interested in an interview with Dr. Amy Newman about opioid research or you’d like to attend the Opioid Symposium, please contact the NIDA press office at email@example.com or 301-443-6245.
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit www.nida.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®